How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...

Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest ...

Novo Nordisk and Eli Lilly currently control 99% of the market, but their dominance may weaken as new entrants introduce ...

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

Novo Nordisk stock was down more than 8% Monday morning after the Danish drugmaker shared new data on its next-generation GLP ...

West Pharmaceutical's strong GLP-1 and biologics segment positions it for growth. Click here to read why WST stock is ...

Q4 2024 Earnings Call Transcript March 6, 2025 Operator: Good day, and thank you for standing by. Welcome to the Fourth ...

When Jenni* started using a medication called liraglutide to lose weight, she noticed changes not just in her appetite, but ...